[The acute and long-term outcome of patients with ST segment elevation myocardial infarction concurrent with chronic

T J Wang1, J L Dong1, Y Wang1

  • 1Coronary Heart Disease Center, National Center for Cardiovascular Diseases and Fuwai Hospital, China Academy of Medical Science and Peking Union Medical College, Beijing 100037, China.

Insights

Patients with ST-segment elevation myocardial infarction (STEMI) and chronic total occlusion (CTO) have higher in-hospital and 1-year mortality after primary percutaneous coronary intervention (PCI). Chronic total occlusion, advanced age, and heart failure history are independent risk factors for mortality.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Research

Background:

  • ST-segment elevation myocardial infarction (STEMI) is a critical condition requiring immediate intervention.
  • Chronic total occlusion (CTO) presents a significant challenge in STEMI management.
  • The impact of concurrent CTO on STEMI outcomes following primary percutaneous coronary intervention (PCI) requires thorough evaluation.

Purpose of the Study:

  • To assess the acute and long-term clinical outcomes of STEMI patients with concurrent CTO undergoing primary PCI.
  • To identify risk factors associated with mortality in this patient population.

Main Methods:

  • A cohort of 11,905 STEMI patients from the China Acute Myocardial Infarction Registry was analyzed.
  • Patients were categorized into CTO and non-CTO groups based on angiography during primary PCI.
  • Propensity score matching (1:3 ratio) was employed to create comparable groups for analysis, focusing on in-hospital and 1-year mortality and major adverse cardiovascular events (MACE).

Main Results:

  • The study identified 931 (7.8%) STEMI patients with CTO.
  • After propensity score matching, in-hospital mortality was significantly higher in the CTO group (4.2%) compared to the non-CTO group (2.4%).
  • One-year outcomes revealed significantly higher rates of all-cause death, cardiac death, and MACE in the CTO group compared to the non-CTO group.

Conclusions:

  • STEMI patients with concurrent CTO experience significantly increased in-hospital and 1-year mortality.
  • Chronic total occlusion, advanced age, and a history of heart failure are identified as independent risk factors for 1-year mortality in STEMI patients.

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
102
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
204
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
69
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
59
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
93